Health Science The rise in patient preference for customized medicines and the development of technology are expected to accelerate the growth of the global regenerative medicine market in the next few years. Analysts forecast the Global Artificial Intelligence in Medicine market to grow at the Highest CAGR during the forecast period 2019-2024. Personalized Medicine market has been evaluated as average growing market and expected that the market will reach high growth figures in coming years. Regenerative Medicine market will register a 23.5% CAGR in terms of revenue, the global market size will reach US$19000 million by 2024, from US$5350 million in 2019. Imaging occupied the largest share in 2017, and liquid biopsy is expected to grow at a high CAGR in the coming years due to high preference of molecular based non-invasive tests, and increasing adoption of personalized medicine. Currently the fourth largest employer in India, the healthcare industry is expected to see a threefold jump in value terms to reach $372 bn by 2022. The global sports medicine market is expected to reach an estimated USD 9,655.6 Mn by the end of 2023. This year, economists expect imports of food, medicine and other goods to plummet by 50 percent or more, as new U.S. sanctions choke off income from the state-run oil industry in Venezuela. Sales of probiotics supplements are projected to reach $4 billion in 2021, with annual growth of 10% from 2019 to 2021. and sales of omega-3 fish / animal oil supplements are expected to top $1.3 billion, per Nutrition Business Journal. The UK government says AI could reduce cancer rates by 10 per cent, saving 20,000 lives a year by 2033, while its widespread adoption could free up an estimated £12.5 billion a year in NHS staff time. 2019 promises to become a year of AI technologies application in healthcare and medicine: People will face with a chance to get new opportunities, physical and mental capabilities they could not even dream of before. North America is expected to attain fastest growth rate and dominated the regenerative medicine market in 2019. Musculoskeletal Disorders application segment accounted for the largest share of the regenerative medicine market in 2019 and oncology segment expected to achive highest growth rate in the future. Europe has emerged as the largest market for herbal medicine: The market in Europe is projected to reach a valuation in excess of USD58,600 Mn by the year 2023. The Global Sports Medicine Market is expected to exceed more than US$12.5 Billion by 2025 at a CAGR of 7.5% in the given forecast period. The US state Department of Labor forecasts nearly 9 percent growth in ambulatory health care jobs statewide from 2017 to 2019, compared to 3 percent growth in nursing and residential care jobs and 2.2 percent growth in hospital jobs. With the continued decline in infectious diseases and the growing prevalence of diet-related noncommunicable diseases, the fraction of the world's total mortality attributable to diet-related noncommunicable diseases is expected to increase from 59% in 2002 to 69% in 2030. Rising number of organ transplantation, and increasing number of products in pipeline that are waiting for approval create major opportunity for the regenerative medicines in the coming years. The global Herbal Medicine market is valued at US$120700 million in 2018 is expected to reach US$203400 million by the end of 2025, growing at a CAGR of 6.7% during 2019-2025. The smart, nimble investors who believe in the care model, install knowledgeable operators with a mission, and let their field leaders make the necessary decisions can and will find success in 2019 and beyond. Asia-Pacific is expected to become one of the most prominent markets by 2023 for precision medicine because of favorable reimbursement policies which will help businesses expand across borders. The Asia-Pacific precision medicine market is projected to grow at a compound annual growth rate of 16.63%, leading to a revenue of USD20.90 Bn by 2023. See full forecast Last updated: 20 July 2019
